These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The effect of zanoterone, a steroidal androgen receptor antagonist, in men with benign prostatic hyperplasia. The Zanoterone Study Group. Berger BM, Naadimuthu A, Boddy A, Fisher HA, McConnell JD, Milam D, Mobley D, Rajfer J. J Urol; 1995 Sep; 154(3):1060-4. PubMed ID: 7543598 [Abstract] [Full Text] [Related]
11. Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881). van Roijen JH, Ooms MP, Weber RF, Brinkmann AO, Grootegoed JA, Vreeburg JT. J Androl; 1997 Sep; 18(1):51-61. PubMed ID: 9089068 [Abstract] [Full Text] [Related]
12. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs. Zhao XF, Yang Y, Wang W, Qiu Z, Zhang P, Wang B. Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194 [Abstract] [Full Text] [Related]
14. Effects of finasteride on the rat ventral prostate. Shao TC, Kong A, Marafelia P, Cunningham GR. J Androl; 1993 Feb; 14(2):79-86. PubMed ID: 8390428 [Abstract] [Full Text] [Related]
17. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS. N Engl J Med; 1992 Oct 22; 327(17):1185-91. PubMed ID: 1383816 [Abstract] [Full Text] [Related]